 | • レポートコード：MRC23Q33067 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、67ページ • 納品方法：Eメール（2-3日） • 産業分類：化学＆材料 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のレフルノミド市場について調査・分析し、世界のレフルノミド市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析（純度99%、純度99.5%）、用途別セグメント分析（関節リウマチ、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Sanofi、DM Pharma、Changzhou Yabang Pharmaceuticalなどが含まれています。世界のレフルノミド市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争による影響は、レフルノミド市場規模を推定する際に考慮しました。本レポートは、レフルノミドの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、レフルノミドに関するビジネス上の意思決定に役立てることを目的としています。 ・レフルノミド市場の概要 - 製品の定義 - レフルノミドのタイプ別セグメント - 世界のレフルノミド市場成長率のタイプ別分析（純度99%、純度99.5%） - レフルノミドの用途別セグメント - 世界のレフルノミド市場成長率の用途別分析（関節リウマチ、その他） - 世界市場の成長展望 - 世界のレフルノミド生産量の推定と予測（2018年-2029年） - 世界のレフルノミド生産能力の推定と予測（2018年-2029年） - レフルノミドの平均価格の推定と予測（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - レフルノミド市場の競争状況およびトレンド ・レフルノミドの地域別生産量 - レフルノミド生産量の地域別推計と予測（2018年-2029年） - 地域別レフルノミド価格分析（2018年-2023年） - 北米のレフルノミド生産規模（2018年-2029年） - ヨーロッパのレフルノミド生産規模（2018年-2029年） - 中国のレフルノミド生産規模（2018年-2029年） - 日本のレフルノミド生産規模（2018年-2029年） - 韓国のレフルノミド生産規模（2018年-2029年） - インドのレフルノミド生産規模（2018年-2029年） ・レフルノミドの地域別消費量 - レフルノミド消費量の地域別推計と予測（2018年-2029年） - 北米のレフルノミド消費量（2018年-2029年） - アメリカのレフルノミド消費量（2018年-2029年） - ヨーロッパのレフルノミド消費量（2018年-2029年） - アジア太平洋のレフルノミド消費量（2018年-2029年） - 中国のレフルノミド消費量（2018年-2029年） - 日本のレフルノミド消費量（2018年-2029年） - 韓国のレフルノミド消費量（2018年-2029年） - 東南アジアのレフルノミド消費量（2018年-2029年） - インドのレフルノミド消費量（2018年-2029年） - 中南米・中東・アフリカのレフルノミド消費量（2018年-2029年） ・タイプ別セグメント：純度99%、純度99.5% - 世界のレフルノミドのタイプ別生産量（2018年-2023年） - 世界のレフルノミドのタイプ別生産量（2024年-2029年） - 世界のレフルノミドのタイプ別価格 ・用途別セグメント：関節リウマチ、その他 - 世界のレフルノミドの用途別生産量（2018年-2023年） - 世界のレフルノミドの用途別生産量（2024年-2029年） - 世界のレフルノミドの用途別価格 ・主要企業のプロファイル：企業情報、製品ポートフォリオ、生産量、価格、動向 Sanofi、DM Pharma、Changzhou Yabang Pharmaceutical ・産業チェーンと販売チャネルの分析 - レフルノミド産業チェーン分析 - レフルノミドの主要原材料 - レフルノミドの販売チャネル - レフルノミドのディストリビューター - レフルノミドの主要顧客 ・レフルノミド市場ダイナミクス - レフルノミドの業界動向 - レフルノミド市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
The global Leflunomide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Leflunomide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Leflunomide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Leflunomide include Sanofi, DM Pharma and Changzhou Yabang Pharmaceutical, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Leflunomide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leflunomide.
The Leflunomide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Leflunomide market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leflunomide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Sanofi
DM Pharma
Changzhou Yabang Pharmaceutical
Segment by Type
99% Purity
99.5% Purity
Segment by Application
Rheumatoid Arthritis
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Leflunomide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Leflunomide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Leflunomide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 Leflunomide Market Overview
1.1 Product Definition
1.2 Leflunomide Segment by Type
1.2.1 Global Leflunomide Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 99% Purity
1.2.3 99.5% Purity
1.3 Leflunomide Segment by Application
1.3.1 Global Leflunomide Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Rheumatoid Arthritis
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Leflunomide Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Leflunomide Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Leflunomide Production Estimates and Forecasts (2018-2029)
1.4.4 Global Leflunomide Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Leflunomide Production Market Share by Manufacturers (2018-2023)
2.2 Global Leflunomide Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Leflunomide, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Leflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Leflunomide Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Leflunomide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Leflunomide, Product Offered and Application
2.8 Global Key Manufacturers of Leflunomide, Date of Enter into This Industry
2.9 Leflunomide Market Competitive Situation and Trends
2.9.1 Leflunomide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Leflunomide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Leflunomide Production by Region
3.1 Global Leflunomide Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Leflunomide Production Value by Region (2018-2029)
3.2.1 Global Leflunomide Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Leflunomide by Region (2024-2029)
3.3 Global Leflunomide Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Leflunomide Production by Region (2018-2029)
3.4.1 Global Leflunomide Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Leflunomide by Region (2024-2029)
3.5 Global Leflunomide Market Price Analysis by Region (2018-2023)
3.6 Global Leflunomide Production and Value, Year-over-Year Growth
3.6.1 North America Leflunomide Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Leflunomide Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Leflunomide Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Leflunomide Production Value Estimates and Forecasts (2018-2029)
4 Leflunomide Consumption by Region
4.1 Global Leflunomide Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Leflunomide Consumption by Region (2018-2029)
4.2.1 Global Leflunomide Consumption by Region (2018-2023)
4.2.2 Global Leflunomide Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Leflunomide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Leflunomide Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Leflunomide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Leflunomide Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Leflunomide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Leflunomide Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Leflunomide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Leflunomide Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Leflunomide Production by Type (2018-2029)
5.1.1 Global Leflunomide Production by Type (2018-2023)
5.1.2 Global Leflunomide Production by Type (2024-2029)
5.1.3 Global Leflunomide Production Market Share by Type (2018-2029)
5.2 Global Leflunomide Production Value by Type (2018-2029)
5.2.1 Global Leflunomide Production Value by Type (2018-2023)
5.2.2 Global Leflunomide Production Value by Type (2024-2029)
5.2.3 Global Leflunomide Production Value Market Share by Type (2018-2029)
5.3 Global Leflunomide Price by Type (2018-2029)
6 Segment by Application
6.1 Global Leflunomide Production by Application (2018-2029)
6.1.1 Global Leflunomide Production by Application (2018-2023)
6.1.2 Global Leflunomide Production by Application (2024-2029)
6.1.3 Global Leflunomide Production Market Share by Application (2018-2029)
6.2 Global Leflunomide Production Value by Application (2018-2029)
6.2.1 Global Leflunomide Production Value by Application (2018-2023)
6.2.2 Global Leflunomide Production Value by Application (2024-2029)
6.2.3 Global Leflunomide Production Value Market Share by Application (2018-2029)
6.3 Global Leflunomide Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Sanofi
7.1.1 Sanofi Leflunomide Corporation Information
7.1.2 Sanofi Leflunomide Product Portfolio
7.1.3 Sanofi Leflunomide Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Sanofi Main Business and Markets Served
7.1.5 Sanofi Recent Developments/Updates
7.2 DM Pharma
7.2.1 DM Pharma Leflunomide Corporation Information
7.2.2 DM Pharma Leflunomide Product Portfolio
7.2.3 DM Pharma Leflunomide Production, Value, Price and Gross Margin (2018-2023)
7.2.4 DM Pharma Main Business and Markets Served
7.2.5 DM Pharma Recent Developments/Updates
7.3 Changzhou Yabang Pharmaceutical
7.3.1 Changzhou Yabang Pharmaceutical Leflunomide Corporation Information
7.3.2 Changzhou Yabang Pharmaceutical Leflunomide Product Portfolio
7.3.3 Changzhou Yabang Pharmaceutical Leflunomide Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Changzhou Yabang Pharmaceutical Main Business and Markets Served
7.3.5 Changzhou Yabang Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Leflunomide Industry Chain Analysis
8.2 Leflunomide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Leflunomide Production Mode & Process
8.4 Leflunomide Sales and Marketing
8.4.1 Leflunomide Sales Channels
8.4.2 Leflunomide Distributors
8.5 Leflunomide Customers
9 Leflunomide Market Dynamics
9.1 Leflunomide Industry Trends
9.2 Leflunomide Market Drivers
9.3 Leflunomide Market Challenges
9.4 Leflunomide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
